Randomized clinical trials of neurally mediated syncope

Area of Science:

• Cardiology
• Neurology
• Clinical Trials

Background:

• Neurally mediated syncope treatments lack robust evidence.
• Numerous drugs have been investigated for vasovagal syncope with limited success.
• Existing research often relies on uncontrolled or short-term studies.

Purpose of the Study:

• To evaluate the evidence for various therapeutic interventions in neurally mediated syncope.
• To assess the efficacy of pharmacologic and non-pharmacologic treatments.
• To provide a comprehensive overview of current treatment options.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) and observational studies.
• Analysis of drug efficacy, including beta-blockers and other agents.
• Evaluation of cardiac pacing therapy for different syncope subtypes.

Main Results:

• Most long-term, placebo-controlled drug trials failed to demonstrate significant benefits.
• Two well-designed trials found no superiority of etilefrine or atenolol over placebo.
• Cardiac pacing shows efficacy in carotid sinus syndrome but is less established for cardioinhibitory vasovagal syncope.

Conclusions:

• Current pharmacologic therapies for vasovagal syncope lack strong supporting evidence.
• Cardiac pacing is beneficial for carotid sinus syndrome, particularly cardioinhibitory and mixed types.
• Further high-quality research is needed to establish effective treatments for vasovagal syncope.